The invention relates to 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives, their preparation and their use in medicine, particularly in the treatment of pain.
[EN] CHEMICAL COMPOUNDS<br/>[FR] COMPOSÉS CHIMIQUES
申请人:RESMAN AS
公开号:WO2015047105A1
公开(公告)日:2015-04-02
The present invention relates to novel compounds of polyfunctionalized polyethylene and polypropylene glycols, their synthesis and their use, in particular as tracers in applications related to oil and gas production, and especially as specific markers of various target fluids.
ELECTROLYTE SALT AND ELECTROLYTE FOR ELECTRICITY STORAGE DEVICE, AND ELECTRICITY STORAGE DEVICE
申请人:NISSHINBO HOLDINGS INC.
公开号:US20150291633A1
公开(公告)日:2015-10-15
Provided is an electrolyte salt comprising a quaternary ammonium cation indicated by formula (1) and a trimethylsilyl alkanesulfonate anion indicated by formula (2).
(In the formula, R
1
-R
4
each independently indicate a C1-4 alkyl group or an alkoxyalkyl group indicated by —(CH
2
)
n
—OR. Any two among R
1
-R
4
can mutually bond and form a ring together with a nitrogen atom to which same have bonded. The remaining two can mutually bond and form a spiro ring having a nitrogen atom as the spiro atom therefor. R indicates a methyl group or an ethyl group. n indicates 1 or 2 and m indicates 2 or 3.)
Decarbonylative ether dissection by iridium pincer complexes
作者:Changho Yoo、Henry M. Dodge、Alexandra H. Farquhar、Kristen E. Gardner、Alexander J. M. Miller
DOI:10.1039/d0sc03736b
日期:——
complexes supported by aminophenylphosphinite (NCOP) pincerligands. The decarbonylation, which involves the cleavage of one C–C bond, one C–Obond, and two C–H bonds, along with formation of two new C–H bonds, was serendipitously discovered upon dehydrochlorination of an iridium(III) complex containing an aza-18-crown-6 ether macrocycle. Intramolecular cleavage of macrocyclic and acyclic ethers was also found
AROMATIC AMINE AR AND BET TARGETING PROTEIN DEGRADATION CHIMERA COMPOUND AND USE
申请人:Hinova Pharmaceuticals Inc.
公开号:EP3971176A1
公开(公告)日:2022-03-23
An aromatic amine androgen receptor (AR) and BET targeting protein degradation chimera compound and its use. Specifically provided is a compound represented by formula I. Experimental results show that the compound can target and degrade both AR and BRD4, and down-regulate the expression of AR and BRD4 proteins; the compound can inhibit the proliferation of a variety of prostate cancer cells; the compound can inhibit the proliferation of a prostate cancer cell line LNCaP/AR, which overexpresses the AR, and can achieve a good inhibition effect on a prostate cancer cell line 22RV1, which is resistant to a marketed prostate cancer drug (enzalutamide); the compound also shows good metabolic stability, and has a good application prospect in the preparation of an AR and/or BET protein degradation targeting chimera, and a drug for the treatment of related diseases regulated by the AR and BET.